TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Communication
KW - Financial Management
KW - Humans
KW - Pennsylvania
KW - Primary Health Care
KW - Hub-and-Spoke systems
KW - Project ECHO
KW - collaborative health systems
KW - Medications for opioid use disorders
KW - telementoring
AU - S. Kawasaki
AU - G. Hwang
AU - K. Buckner
AU - E. Francis
AU - S. Huffnagle
AU - J. Kraschnewski
AU - P. Vulgamore
AU - A. Lucas
AU - J. Barbour
AU - M. Crawford
AU - L. Thomas
AU - M. Fuller
AU - J. Meyers
AU - G. Swartzentruber
AU - R. Levine
A1 - 
AB - Background: The opioid epidemic continues to erode communities across Pennsylvania (PA). Federal and PA state programs developed grants to establish Hub and Spoke programs for the expansion of medications for opioid use disorders (MOUD). Employing the telementoring platform Project ECHO (Extension for Community Health Outcomes), Penn State Health engaged the other seven grant awardees in a Collaborative Health Systems (CHS) ECHO. We conducted key informant interviews to better understand impact of the CHS ECHO on health systems collaboration and opioid crisis efforts. Methods: For eight one-hour sessions, each awardee presented their unique strategies, challenges, and opportunities. Using REDCap, program characteristics, such as number of waivered prescribers and number of patients served were collected at baseline. After completion of the sessions, key informant interviews were conducted to assess the impact of CHS ECHO on awardee's programs. Results: Analysis of key informant interviews revealed important themes to address opioid crisis efforts, including the need for strategic and proactive program reevaluation and the convenience of collaborative peer learning networks. Participants expressed benefits of the CHS ECHO including allowing space for discussion of challenges and best practices and facilitating conversation on collaborative targeted advocacy and systems-level improvements. Participants further reported bolstered motivation and confidence. Conclusions: Utilizing Project ECHO provided a bidirectional platform of learning and support that created important connections between institutions working to combat the opioid epidemic. CHS ECHO was a unique opportunity for productive and convenient peer learning across external partners. Open dialogue developed during CHS ECHO can continue to direct systems-levels improvements that benefit individual and population outcomes.
AD - Pennsylvania Psychiatric Institute, Hershey, Pennsylvania, USA.; Penn State Project ECHO, Hershey, Pennsylvania, USA.; Penn State Project ECHO, Hershey, Pennsylvania, USA.; Penn State Project ECHO, Hershey, Pennsylvania, USA.; Pennsylvania Psychiatric Institute, Hershey, Pennsylvania, USA.; Penn State College of Medicine, Hershey, Pennsylvania, USA.; Temple Health, Philadelphia, Pennsylvania, USA.; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.; Geisinger, Danville, Virginia, USA.; Wellspan Health, York, Pennsylvania, USA.; The Wright Center for Community Health, Scranton, Pennsylvania, USA.; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.; UPMC Center for High Value Health Care, Pittsburgh, Pennsylvania, USA.; UPMC Pinnacle Center for Addiction Recovery, Pittsburgh, Pennsylvania, USA.; The United States Department of Health and Human Services, Washington, DC, USA.
BT - Substance abuse
C5 - Financing & Sustainability; HIT & Telehealth; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1080/08897077.2021.2007519
IS - 1
JF - Substance abuse
LA - eng
M1 - Journal Article
N2 - Background: The opioid epidemic continues to erode communities across Pennsylvania (PA). Federal and PA state programs developed grants to establish Hub and Spoke programs for the expansion of medications for opioid use disorders (MOUD). Employing the telementoring platform Project ECHO (Extension for Community Health Outcomes), Penn State Health engaged the other seven grant awardees in a Collaborative Health Systems (CHS) ECHO. We conducted key informant interviews to better understand impact of the CHS ECHO on health systems collaboration and opioid crisis efforts. Methods: For eight one-hour sessions, each awardee presented their unique strategies, challenges, and opportunities. Using REDCap, program characteristics, such as number of waivered prescribers and number of patients served were collected at baseline. After completion of the sessions, key informant interviews were conducted to assess the impact of CHS ECHO on awardee's programs. Results: Analysis of key informant interviews revealed important themes to address opioid crisis efforts, including the need for strategic and proactive program reevaluation and the convenience of collaborative peer learning networks. Participants expressed benefits of the CHS ECHO including allowing space for discussion of challenges and best practices and facilitating conversation on collaborative targeted advocacy and systems-level improvements. Participants further reported bolstered motivation and confidence. Conclusions: Utilizing Project ECHO provided a bidirectional platform of learning and support that created important connections between institutions working to combat the opioid epidemic. CHS ECHO was a unique opportunity for productive and convenient peer learning across external partners. Open dialogue developed during CHS ECHO can continue to direct systems-levels improvements that benefit individual and population outcomes.
PP - United States
PY - 2022
SN - 1547-0164; 0889-7077
SP - 892
EP - 900
EP - 
T1 - Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania
T2 - Substance abuse
TI - Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania
U1 - Financing & Sustainability; HIT & Telehealth; Opioids & Substance Use
U2 - 35192446
U3 - 10.1080/08897077.2021.2007519
VL - 43
VO - 1547-0164; 0889-7077
Y1 - 2022
ER -